HEMATOLOGY101.Com

* Blood Research, Blood Diseases

* Anemia, Lukemia, Bone Marrow

* Hematology Symptoms, Research

* Hematology News, Info, Resources

Filter= ERCP

 

   Exact Time

 

  * Search on anything here:
        Like us:      Follow us:   

 

 * Featured New Sites! =>

 

    

 

    

   

 

 

  

 

* Z101.COM *

 

** Useful Links **
  • Obituaries101
  • Accident Lawyers101
  • FIRE101
  •  FIRE101 MOBILE
  • POLICE101
  • Protect101
  • School Directions

    •  

  • ** Car Websites **
  •   Corvettes 101
  •   Mustangs 101
  • New Cars 101
  • Luxury Cars 101
  • Exotic Cars 101

    •  

  • ** Sports Websites **
  • Lacrosse 101
  • Volleyball 101
  • Cross Country 101
  • Rowing 101
  • Rugby 101
  • Softball 101
  • Water Polo 101
  • Karate 101
  • TKD 101

    •  

  • ** Medical Websites **
  • Internal Medicine 101
  • Sports Medicine 101
  • Nursing 101
  • OccupationalTherapy101
  • Orthopedics 101
  • Podiatry 101
  • Psychiatry 101

    •  

  • Diseases 101
  • Depression 101
  • Lyme Disease 101
  • OCD101

    •  

  • ** Lawyers Websites **
  • * Find Lawyers 101 *
  • Accident Lawyers 101
  • Defense Lawyers 101
  • Divorce Lawyers 101
  • DWI Lawyers 101
  • Malpractice Lawyers 101
  • Personal Injury Lawyers 101
  • Real Estate Lawyers 101
  • Tax Lawyers 101

    •  

     

     

     

     

    * Hematology101 SEARCH *

       *Filter: "ERCP"

      

    ERCP: What It Is, Why It’s Done, Procedure & Complications
    ERCP stands for endoscopic retrograde cholangiopancreatography. It’s a type of imaging test that allows healthcare providers to look inside your bile ducts and pancreatic ducts.

    Endoscopic Retrograde Cholangiopancreatography (ERCP)
    Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure that combines upper gastrointestinal (GI) endoscopy and x-rays to find and treat problems of the bile and pancreatic ducts.

    ERCP: Procedure Steps, Indications, Surgery, Complications
    Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure to examine and diagnose diseases of the liver, bile ducts, and pancreas.

    Endoscopic Retrograde Cholangiopancreatography (ERCP)
    What is ERCP? Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure to diagnose and treat problems in the liver, gallbladder, bile ducts, and pancreas. It combines X-ray and an endoscope—a long, flexible, lighted tube.

    What Is ERCP Test (Endoscopic Retrograde Cholangiopancreatogram) - WebMD
    What Is an ERCP? ERCP, which is short for endoscopic retrograde cholangiopancreatography, is a procedure used to diagnose and treat problems related to pancreatic ducts and bile ducts.

    Endoscopic retrograde cholangiopancreatography - Wikipedia
    Endoscopic retrograde cholangiopancreatography (ERCP) is a technique that combines the use of endoscopy and fluoroscopy to diagnose and treat certain problems of the biliary or pancreatic ductal systems. It is primarily performed by highly skilled and specialty trained gastroenterologists.

    ERCP: A Patient’s Guide - American College of Gastroenterology
    Endoscopic retrograde cholangiopancreatography, or ERCP, is an endoscopic test that is used to examine and treat problems of the bile ducts, pancreatic ducts, and gallbladder.

    ERCP | General Surgery
    Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure that combines upper gastrointestinal (GI) endoscopy and x-rays to treat problems of the bile and pancreatic ducts.

    ERCP: Preparation, Recovery, Long-Term Care - Verywell Health
    Endoscopic retrograde cholangiopancreatography, or ERCP, is a procedure used for diagnosis and treatment of biliary obstruction.

    ERCP (endoscopic retrograde cholangio pancreatography) - Overview
    An ERCP is used to diagnose and treat problems with the biliary system. Find out more about what an ERCP is and why it is done.

     

     

     

           * Hematology101 LATEST NEWS *

               *Filter: "ERCP"

     

     

  •  NEW JOBS
  • Obituaries101
  • FIRE101
  • POLICE101
  • PROTECT101
  • School Directions
    		•
  • * POPULAR:  
  • Democrats101
  • Republicans101
  • NewCars101
  • LuxuryCars101
  • CarbonCapture101
    		•

    *Sponsored: *Teleflora Flowers GREAT Deals!

     

    *Click a bouquet and send it today:
               

     

        ~~> 30% Off Discount Page - ALL FLOWERS! <~~

     

    *More Savings:      Get well: 20%    Sympathy & Funeral: 20%

     

             Birthday: $15    New Baby 15% off    Anniversary 15% off
    Hematology Symptoms
    • Fatigue and Weakness: Persistent lack of energy caused by anemia, where reduced red blood cell levels limit oxygen delivery to body tissues.
    • Unexplained Bruising and Petechiae: Easy bruising or pinpoint red spots on the skin resulting from low platelet counts or impaired blood clotting mechanisms.
    • Frequent or Recurrent Infections: Increased susceptibility to illness due to leukopenia or dysfunctional white blood cells failing to protect against pathogens.
    • Swollen Lymph Nodes: Painless enlargement of lymph glands in the neck, armpits, or groin often associated with hematologic malignancies like lymphoma or leukemia.
    • Unexplained Fever and Night Sweats: Systemic symptoms frequently tied to active hematologic disorders or hypermetabolic states driven by bone marrow dysfunction.
    • Shortness of Breath and Palpitations: Respiratory distress or rapid heart rate during light activity as the cardiovascular system attempts to compensate for severe anemia.
    • Bone or Joint Pain: Deep, aching discomfort caused by the expansion of abnormal blood cells within the bone marrow space.

      

    * Useful Government Health Sites:                               
    Hematology History
    • 1658: Discovery of Red Blood Cells Jan Swammerdam becomes the first person to observe red blood cells under a microscope in frog blood, followed closely by Antonie van Leeuwenhoek in human blood.
    • 1901: Discovery of ABO Blood Groups Karl Landsteiner identifies the A, B, and O blood groups, laying the scientific foundation for safe blood transfusions and earning the Nobel Prize.
    • 1910: First Description of Sickle Cell Anemia James B. Herrick publishes the first detailed medical account of elongated, sickle-shaped red blood cells in a dental student from Grenada.
    • 1940: Identification of the Rh Factor Karl Landsteiner and Alexander Wiener discover the Rh factor, drastically reducing fatal transfusion reactions and resolving hemolytic disease of the newborn.
    • 1948: First Remission of Childhood Leukemia Sidney Farber demonstrates that aminopterin (a folic acid antagonist) can achieve temporary remissions in acute lymphoblastic leukemia, marking the birth of modern cancer chemotherapy.
    • 1957: First Successful Human Bone Marrow Transplant E. Donnall Thomas performs the first successful intravenous infusion of bone marrow stem cells into leukemia patients treated with radiation therapy.
    • 1960: Discovery of the Philadelphia Chromosome Peter Nowell and David Hungerford identify a specific chromosomal abnormality in chronic myeloid leukemia, establishing the genetic basis of cancer.
    Current Hematology Research
    • Gene Therapy for Sickle Cell Disease: Advances in CRISPR-based gene editing are enabling targeted modifications in patient hematopoietic stem cells to restore healthy hemoglobin production.
    • CAR-T Cell Innovations in Hematologic Malignancies: Next-generation chimeric antigen receptor T-cell therapies are expanding target antigens to overcome resistance mechanisms in relapsed leukemia and lymphoma.
    • Minimal Residual Disease (MRD) Tracking: High-throughput sequencing and digital PCR techniques are improving early detection of residual cancer cells to guide personalized treatment timelines.
    • Bispecific Antibodies in Multiple Myeloma: Dual-targeting immunotherapies are showing high response rates by simultaneously binding to tumor antigens and cytotoxic T cells to induce targeted lysis.
    • Novel Factor VIII Mimetic Agents for Hemophilia: Long-acting subcutaneous non-factor replacement therapies continue to lower bleeding rates and reduce the burden of frequent intravenous infusions.
    • JAK Inhibitors in Myelofibrosis: Targeted kinase inhibition therapies are demonstrating significant efficacy in reducing splenomegaly and improving constitutional symptoms in chronic myeloproliferative neoplasms.
    • Complement System Targeted Therapies in PNH: Next-generation C3 and C5 complement inhibitors offer improved control over extravascular hemolysis in paroxysmal nocturnal hemoglobinuria.

    HEMATOLOGY101.COM --- Hematology Information, News, and Resources, Lots More

    Need to Find information on any subject? ASK THE HEMATOLOGY101 GURU!

     * Contact us:  support@z101.com
                                            
    Copyright 2010-2026  HEMATOLOGY101.COM